Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGL | P06737 | 1/20 | 0.43 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.42 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.41 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.41 |
| ▸ | SLC5A2 | P31639 | 6/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29050759 | 1.00 | PYGL (0.43) | PYGLCD209LGALS9LGALS1LGALS3 | |
| SCHEMBL1378660 | 1.00 | PYGL (0.43) | PYGLCD209LGALS9LGALS1LGALS3 | |
| SCHEMBL27931661 | 1.00 | PYGL (0.43) | PYGLCD209LGALS9LGALS1LGALS3 | |
| SCHEMBL22125692 | 1.00 | PYGL (0.43) | PYGLCD209LGALS9LGALS1LGALS3 | |
| SCHEMBL27531539 | 1.00 | PYGL (0.43) | PYGLCD209LGALS9LGALS1LGALS3 | |
| Water SCHEMBL8679667 | 0.99 | PYGL (0.42) | PYGLCD209LGALS9LGALS1LGALS3 | |
| SCHEMBL4518617 | 0.88 | SLC5A2 (0.38) | PYGLCD209SLC5A2 | |
| SCHEMBL6844267 | 0.84 | KDM4E (0.36) | PYGLSLC5A2 | |
| SCHEMBL7763290 | 0.82 | PDK2 (0.39) | SLC5A2 | |
| SCHEMBL4527040 | 0.82 | SLC5A2 (0.34) | PYGLCD209LGALS9LGALS1LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10675311-B2 | Lactic acid bacterium | KANEKA CORPORATION (JP) | 2020-06-09 | — | — | US | claimed |
| US-20170232046-A1 | NOVEL LACTIC ACID BACTERIUM | KANEKA CORPORATION (JP) | 2017-08-17 | — | — | US | claimed |
| CN-101535496-B | Genetically engineered biological indicator | AMERICAN STERILIZER CO. (US) | 2015-12-02 | — | — | CN | claimed |
| EP-2881459-A1 | NOVEL LACTIC ACID BACTERIUM | Kaneka Corporation (JP) | 2015-06-10 | — | — | EP | claimed |
| US-20150139970-A1 | NOVEL LACTIC ACID BACTERIUM | KANEKA CORPORATION (JP) | 2015-05-21 | — | — | US | claimed |
| EP-2084293-B1 | GENETICALLY ENGINEERED BIOLOGICAL INDICATOR | AMERICAN STERILIZER CO (US) | 2014-08-13 | — | — | EP | claimed |
| CN-101541944-B | Sterilization indicator | AMERICAN STERILIZER CO | 2013-05-22 | — | — | CN | claimed |
| CN-101541944-A | Sterilization indicator | AMERICAN STERILIZER CO (US) | 2009-09-23 | — | — | CN | claimed |
| CN-101535496-A | Genetically engineered biological indicator | AMERICAN STERILIZER CO (US) | 2009-09-16 | — | — | CN | claimed |
| US-20020182600-A1 | Method for assaying biological and other constituents using synthetic nucleounits in lateral flow, liquid, and dry chemistry techniques | SMITH JACK V (US) | 2002-12-05 | — | — | US | claimed |
| EP-2384457-B1 | COATING COMPOSITIONS | MERCK PATENT GMBH (DE) | 2022-07-06 | — | — | EP | disclosed |
| EP-3494206-B1 | LACTIC BACTERIA AND THE USE THEREOF FOR THE PREVENTIVE, INHIBITORY AND/OR REDUCTIVE TREATMENT OF THE FORMATION OF BACTERIAL BIOFILMS | PROBIOTICAL SPA (IT) | 2021-07-07 | — | — | EP | disclosed |
| EP-3792343-A1 | NOVEL STRAIN HAVING PROPHYLACTIC OR THERAPEUTIC EFFECT ON CANCER | Genome and Company (KR) | 2021-03-17 | — | — | EP | disclosed |
| EP-2951279-B1 | METHOD AND CULTURE DEVICE FOR DETECTING YEASTS AND MOLDS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-12-09 | — | — | EP | disclosed |
| US-10675311-B2 | Lactic acid bacterium | KANEKA CORPORATION (JP) | 2020-06-09 | — | — | US | disclosed |
| EP-0817789-A1 | BIS-MALEIMIDO CROSS-LINKING AGENTS | BOEHRINGER MANNHEIM CORPORATION (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1997027203-A1 | BIS-MALEIMIDO CROSS-LINKING AGENTS | BOEHRINGER MANNHEIM CORPORATION (US) | 1997-07-31 | — | — | WO | disclosed |
| WO-1997027320-A1 | ASSAYS USING CROSS-LINKED POLYPEPTIDE FRAGMENTS OF β-GALACTOSIDASE | BOEHRINGER MANNHEIM CORPORATION (US) | 1997-07-31 | — | — | WO | disclosed |
| EP-0474662-A1 | BACTERIAL GENES. | ICI PLC (GB) | 1992-03-18 | — | — | EP | disclosed |
| WO-1990013651-A1 | BACTERIAL GENES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-11-15 | — | — | WO | disclosed |